Page last updated: 2024-10-27

gemfibrozil and Glucose Intolerance

gemfibrozil has been researched along with Glucose Intolerance in 1 studies

Glucose Intolerance: A pathological state in which BLOOD GLUCOSE level is less than approximately 140 mg/100 ml of PLASMA at fasting, and above approximately 200 mg/100 ml plasma at 30-, 60-, or 90-minute during a GLUCOSE TOLERANCE TEST. This condition is seen frequently in DIABETES MELLITUS, but also occurs with other diseases and MALNUTRITION.

Research Excerpts

ExcerptRelevanceReference
"In Ppara-null mice, MFD treatment increased body weight, adipose tissue, serum TG and impaired glucose tolerance."1.48PPARĪ±-independent action against metabolic syndrome development by fibrates is mediated by inhibition of STAT3 signalling. ( Dai, M; Gonzalez, FJ; Hua, H; Huang, J; Lin, H; Liu, A; Liu, L; Wang, F; Xi, Y; Xu, G; Yang, J; Zhao, T, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hua, H1
Yang, J1
Lin, H1
Xi, Y1
Dai, M1
Xu, G1
Wang, F1
Liu, L1
Zhao, T1
Huang, J1
Gonzalez, FJ1
Liu, A1

Other Studies

1 other study available for gemfibrozil and Glucose Intolerance

ArticleYear
PPARĪ±-independent action against metabolic syndrome development by fibrates is mediated by inhibition of STAT3 signalling.
    The Journal of pharmacy and pharmacology, 2018, Volume: 70, Issue:12

    Topics: 3T3-L1 Cells; Adipose Tissue; Animals; Body Weight; Fenofibrate; Fibric Acids; Gemfibrozil; Glucose

2018